A double‐blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism-Reference-Cited by-同舟云学术

A double‐blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism

Published:2019-02-04 Issue:4 Volume:39 Page:684-693
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Sahney Amrish¹,Sharma Barjesh Chander¹,Jindal Ankur¹^ORCID,Anand Lovkesh¹,Arora Vinod¹,Vijayaraghavan Rajan¹,Dhamija Ravinder Mohan²,Kumar Guresh³,Bhardwaj Ankit³,Sarin Shiv Kumar¹^ORCID

Affiliation:

1. Department of Hepatology Institute of Liver and Biliary Sciences New Delhi India

2. Department of Neurology Institute of Liver and Biliary Sciences New Delhi India

3. Department of Clinical Research Institute of Liver and Biliary Sciences New Delhi India

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14024

Reference24 articles.

1. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy

2. Neuronal cell death in hepatic encephalopathy

3. Acquired hepatocerebral degeneration: clinical characteristics and MRI findings

4. DISTRIBUTION OF CEREBRAL LESIONS IN ACQUIRED HEPATOCEREBRAL DEGENERATION

5. La, cirrhosehepatique avec alterations dans les centre nerveuxevoluant chez des sujetsd’agemoyen. Nouvelle Iconographie de la Salpetriere;Woerkem W;Clinique des Maladies du SystemeNerveux,1914

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Experimental Evidence of Cirrhosis-Related Parkinsonism;Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease;2023-08-04

2. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy;Journal of Hepatology;2022-09

3. Bromocriptine therapy: Review of mechanism of action, safety and tolerability;Clinical and Experimental Pharmacology and Physiology;2022-06-22

4. Manganese, a Likely Cause of 'Parkinson's in Cirrhosis', a Unique Clinical Entity of Acquired Hepatocerebral Degeneration;Cureus;2020-09-14

5. Novel Therapeutics for the Treatment of Alzheimer’s and Parkinson’s Disease;Current Pharmaceutical Design;2020-03-25